1. Home
  2. PMCB vs ELAB Comparison

PMCB vs ELAB Comparison

Compare PMCB & ELAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • ELAB
  • Stock Information
  • Founded
  • PMCB 1996
  • ELAB 2020
  • Country
  • PMCB United States
  • ELAB United States
  • Employees
  • PMCB N/A
  • ELAB N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • ELAB
  • Sector
  • PMCB Health Care
  • ELAB
  • Exchange
  • PMCB Nasdaq
  • ELAB Nasdaq
  • Market Cap
  • PMCB 7.6M
  • ELAB 6.6M
  • IPO Year
  • PMCB N/A
  • ELAB 2023
  • Fundamental
  • Price
  • PMCB $1.05
  • ELAB $2.16
  • Analyst Decision
  • PMCB
  • ELAB
  • Analyst Count
  • PMCB 0
  • ELAB 0
  • Target Price
  • PMCB N/A
  • ELAB N/A
  • AVG Volume (30 Days)
  • PMCB 8.5K
  • ELAB 1.5M
  • Earning Date
  • PMCB 08-12-2025
  • ELAB 08-13-2025
  • Dividend Yield
  • PMCB N/A
  • ELAB N/A
  • EPS Growth
  • PMCB N/A
  • ELAB N/A
  • EPS
  • PMCB 1.29
  • ELAB N/A
  • Revenue
  • PMCB N/A
  • ELAB N/A
  • Revenue This Year
  • PMCB N/A
  • ELAB N/A
  • Revenue Next Year
  • PMCB N/A
  • ELAB N/A
  • P/E Ratio
  • PMCB $0.82
  • ELAB N/A
  • Revenue Growth
  • PMCB N/A
  • ELAB N/A
  • 52 Week Low
  • PMCB $1.00
  • ELAB $1.95
  • 52 Week High
  • PMCB $2.42
  • ELAB $840.00
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 47.26
  • ELAB 45.40
  • Support Level
  • PMCB $1.00
  • ELAB $1.96
  • Resistance Level
  • PMCB $1.07
  • ELAB $2.26
  • Average True Range (ATR)
  • PMCB 0.05
  • ELAB 0.22
  • MACD
  • PMCB 0.01
  • ELAB 0.03
  • Stochastic Oscillator
  • PMCB 39.78
  • ELAB 17.95

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About ELAB Elevai Labs Inc.

PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.

Share on Social Networks: